Flora Growth Corp. (NASDAQ:FLGC – Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 212,000 shares, an increase of 43.7% from the September 30th total of 147,500 shares. Based on an average daily trading volume, of 181,800 shares, the days-to-cover ratio is presently 1.2 days. Currently, 2.3% of the company’s stock are short sold.
Analyst Upgrades and Downgrades
Separately, Alliance Global Partners reaffirmed a “neutral” rating on shares of Flora Growth in a research report on Thursday, August 15th.
View Our Latest Analysis on Flora Growth
Flora Growth Price Performance
Flora Growth (NASDAQ:FLGC – Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.17). Flora Growth had a negative return on equity of 161.06% and a negative net margin of 21.56%. The company had revenue of $15.68 million for the quarter, compared to the consensus estimate of $20.74 million. Research analysts anticipate that Flora Growth will post -0.48 EPS for the current year.
Hedge Funds Weigh In On Flora Growth
A hedge fund recently raised its stake in Flora Growth stock. Renaissance Technologies LLC increased its position in shares of Flora Growth Corp. (NASDAQ:FLGC – Free Report) by 105.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 159,595 shares of the company’s stock after buying an additional 81,982 shares during the period. Renaissance Technologies LLC owned 1.19% of Flora Growth worth $163,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 36.01% of the company’s stock.
Flora Growth Company Profile
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Further Reading
- Five stocks we like better than Flora Growth
- 3 Warren Buffett Stocks to Buy Now
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- ETF Screener: Uses and Step-by-Step Guide
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.